about
A-kinase anchoring protein mediates TRPV1 thermal hyperalgesia through PKA phosphorylation of TRPV1Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca²⁺ channel complexModels of inflammation: Carrageenan- or complete Freund's Adjuvant (CFA)-induced edema and hypersensitivity in the rat.Nerve growth factor alters microtubule targeting agent-induced neurotransmitter release but not MTA-induced neurite retraction in sensory neurons.Rapid pain modulation with nuclear receptor ligands.Long-term exposure to PGE2 causes homologous desensitization of receptor-mediated activation of protein kinase A.Capsaicin-evoked iCGRP release from human dental pulp: a model system for the study of peripheral neuropeptide secretion in normal healthy tissue.Challenges and opportunities identifying therapeutic targets for chemotherapy-induced peripheral neuropathy resulting from oxidative DNA damage.Furanocoumarins are a novel class of modulators for the transient receptor potential vanilloid type 1 (TRPV1) channel.Paclitaxel alters the evoked release of calcitonin gene-related peptide from rat sensory neurons in culture.Tumor necrosis factor alpha and interleukin-1beta stimulate the expression of cyclooxygenase II but do not alter prostaglandin E2 receptor mRNA levels in cultured dorsal root ganglia cells.Paclitaxel inhibits the activity and membrane localization of PKCα and PKCβI/II to elicit a decrease in stimulated calcitonin gene-related peptide release from cultured sensory neurons.PAR-2 agonists activate trigeminal nociceptors and induce functional competence in the delta opioid receptor.Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C.DNA damage mediates changes in neuronal sensitivity induced by the inflammatory mediators, MCP-1 and LPS, and can be reversed by enhancing the DNA repair function of APE1.Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic.Models of Inflammation: Carrageenan Air Pouch.Models of inflammation: carrageenan air pouch.Chemotherapy-induced peripheral neuropathyNo pain, no gain? The effects of pain-promoting neuropeptides and neurotrophins on fracture healingPathogenesis of paclitaxel-induced peripheral neuropathy: A current review of in vitro and in vivo findings using rodent and human model systems
P50
Q28568896-3C079BC2-A71D-43CE-9EE8-21B61A089D46Q35561043-99190CFD-ECB1-418C-A5F3-7EB01A4EFFB5Q36384132-AB2F73A6-9759-41B0-ADC6-2E460E9EF3A3Q36884527-1028DC6C-2889-44BD-B2F8-CAB895C60002Q36964412-F88C63F8-AAE6-42FC-AA0A-98372280B09AQ37084924-6D86E6C8-3E8C-4CAD-ACD6-2072ED0DE3B8Q37381098-C3B9457F-C27C-49BF-9215-3067CC43F8C8Q37655675-E239EA28-FB97-4395-8447-FF50B889CBBCQ37683369-C4EA869A-226C-431F-A3A8-181A6160A81FQ39283600-0D1475C2-0304-4740-9993-3E5CAE64E319Q42472310-167C9C45-02D9-498E-A3F2-6D26AA475CE4Q42508432-296F8718-1A07-4061-977C-AF84174CD6E7Q44330938-750B623D-3E40-46B0-9354-72C7D3D27BF6Q44589947-899DAFED-5C90-4B98-A33D-844F4E840EB5Q46297733-FCBBDCA5-F9DD-40F5-A61E-B04D458A84ACQ51825149-55BD854D-7464-4925-B167-2282C9373FECQ53142664-B77CE9E8-17CD-420D-B2A5-AF4917C7697CQ55186329-35893FCC-B4DC-4183-8B17-6E25AAE5E143Q86877099-F3FD4A25-4D50-450F-9B0F-0140CDB9687AQ91246353-C19024C4-6BEA-4077-B41A-7D357C1C09D8Q91410259-43E305AB-242E-4B44-9E53-AEF3B1AB4FB0
P50
description
researcher
@en
name
Jill C. Fehrenbacher
@en
Jill C. Fehrenbacher
@es
type
label
Jill C. Fehrenbacher
@en
Jill C. Fehrenbacher
@es
prefLabel
Jill C. Fehrenbacher
@en
Jill C. Fehrenbacher
@es